Use of Blood Donor Screening to Monitor Prevalence of HIV and Hepatitis B and C Viruses, South Africa
Marion Vermeulen, Ronel Swanevelder, Dhuly Chowdhury, Charlotte Ingram1
, Ravi Reddy, Evan M. Bloch, Brian S. Custer, Edward L. Murphy
, and for the NHLBI Recipient Epidemiology and Donor evaluation Study-III (REDS-III) International Component
Author affiliations: South African National Blood Service, Johannesburg, South Africa (M. Vermeulen, R. Swanevelder, C. Ingram, R. Reddy); RTI International, Rockville, Maryland, USA (D. Chowdhury); Johns Hopkins University School of Medicine, Baltimore, Maryland, USA (E.M. Bloch); Blood Systems Research Institute, San Francisco, California, USA (B.S. Custer, E.L. Murphy); University of California, San Francisco (E.L. Murphy)
Figure. Overall prevalence of HIV (A) and hepatitis B virus (B) in South Africa, by province, among persons making blood donations through the South African National Blood Service, January 2012–September 2015. Pink indicates a significantly higher odds ratio and green indicates a lower odds ratio compared with Gauteng Province (Johannesburg region) and adjusting for other factors. Unadjusted prevalences are shown in parentheses. NA, not applicable.
Page created: August 17, 2017
Page updated: August 17, 2017
Page reviewed: August 17, 2017
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.